Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis

Cardiovascular Research

Volumn 107, Issue 1, 2015, Pages 32-44

  Flemming, Sven ^a   Burkard, Natalie ^a   Renschler, Melanie ^a   Vielmuth, Franziska ^b   Meir, Michael ^a   Schick, Martin Alexander ^a   Wunder, Christian ^a   Germer, Christoph Thomas ^a   Spindler, Volker ^b   Waschke, Jens ^b   Schlegel, Nicolas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

ADAM10; Endothelial barrier; Inflammation; Metalloproteinases; VE cadherin

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALBUMIN; BACTERIUM LIPOPOLYSACCHARIDE; CREATININE; DISINTEGRIN; METALLOPROTEINASE INHIBITOR; PHOSPHODIESTERASE IV; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; 3-(FORMYLHYDROXYAMINO)-2-(3-PHENYL-1-PROPYL)BUTANOIC ACID (2,2-DIMETHYL-1-METHYLCARBAMOYL-1-PROPYL)AMIDE; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CADHERIN; DIPEPTIDE; HYDROXAMIC ACID; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PHOSPHODIESTERASE IV INHIBITOR; SECRETASE;

AGED; APACHE; ARTICLE; ATOMIC FORCE MICROSCOPY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; DOSE RESPONSE; ENDOTHELIAL BARRIER DISRUPTION; ENDOTHELIUM; ENZYME INHIBITION; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE COUNT; MALE; MASS SPECTROMETRY; MEMBRANE PERMEABILITY; MOLECULAR MECHANICS; MOLECULAR SIZE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SUPERNATANT; ANTAGONISTS AND INHIBITORS; CELL CULTURE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY;

ADAM PROTEINS; AGED; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD; CADHERINS; CELLS, CULTURED; DIPEPTIDES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXAMIC ACIDS; INFLAMMATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PERMEABILITY; PHOSPHODIESTERASE 4 INHIBITORS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936777240     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvv144     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
2. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41: 580-637.
3. Moerer O, Quintel M. Sepsis in adult patients - definitions, epidemiology and economic aspects. Internist (Berl) 2009;50:788, 790-784, 796-788.
4. Cinel I, Dellinger RP. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 2007;20:345-352.
5. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009;11:e19.
6. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 2011;3:88ps25.
7. Lee WL, Liles WC. Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol 2011;18:191-196.
8. Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci 2013;126: 2545-2549.
9. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008;121:2115-2122.
10. Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 2009; 221:750-759.
11. Koga S, Morris S, Ogawa S, Liao H, Bilezikian JP, Chen G, Thompson WJ, Ashikaga T, Brett J, Stern DM, Pinsky DJ. TNF modulates endothelial properties by decreasing cAMP. Am J Physiol 1995;268:C1104-C1113.
12. Schlegel N, Baumer Y, Drenckhahn D, Waschke J. Lipopolysaccharide-induced endothelial barrier breakdown is cyclic adenosine monophosphate dependent in vivo and in vitro. Crit Care Med 2009;37:1735-1743.
13. Schlegel N, Waschke J. Impaired cAMP and Rac 1 signaling contribute to TNF-alpha-induced endothelial barrier breakdown in microvascular endothelium. Microcirculation 2009;16:521-533.
14. Seybold J, Thomas D, Witzenrath M, Boral S, Hocke AC, Burger A, Hatzelmann A, Tenor H, Schudt C, Krull M, Schutte H, Hippenstiel S, Suttorp N. Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability. Blood 2005;105:3569-3576.
15. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol 1998;274:H1885-H1894.
16. Heupel W-M, Efthymiadis A, Schlegel N, Muller T, Baumer Y, Baumgartner W, Drenckhahn D,Waschke J. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo. J Cell Sci 2009;122: 1616-1625.
17. Zhang RY, Liu YY, Li L, Cui W, Zhao KJ, Huang WC, Gu XW, Liu W, Wu J, Min D, Mao EQ, Tang YQ. Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis. J Int Med Res 2010;38:1497-1506.
18. Dreymueller D, Pruessmeyer J, Groth E, Ludwig A. The role of ADAM-mediated shedding in vascular biology. Eur J Cell Biol 2012;91:472-485.
19. Burke-Gaffney A, Evans TW. Lest we forget the endothelial glycocalyx in sepsis. Crit Care 2012;16:121.
20. Henrich M, Gruss M,Weigand MA. Sepsis-induced degradation of endothelial glycocalix. Scientific World J 2010;10:917-923.
21. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 2008;102:1192-1201.
22. Ponnuchamy B, Khalil RA. Role of ADAMs in endothelial cell permeability: cadherin shedding and leukocyte rolling. Circ Res 2008;102:1139-1142.
23. Schlegel N, Burger S, Golenhofen N,Walter U, Drenckhahn D,Waschke J. The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am J Physiol Cell Physiol 2008;294:C178-C188.
24. Ludwig A, Hundhausen C, Lambert MH, Broadway N, Andrews RC, Bickett DM, Leesnitzer MA, Becherer JD. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen 2005;8:161-171.
25. Baumer Y, Drenckhahn D,Waschke J. cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium. Histochem Cell Biol 2008;129:765-778.
26. Satpute SK, Banpurkar AG, Dhakephalkar PK, Banat IM, Chopade BA. Methods for investigating biosurfactants and bioemulsifiers: a review. Crit Rev Biotechnol 2010;30: 127-144.
27. Gotsch U, Borges E, Bosse R, Bggemeyer E, Simon M, Mossmann H, Vestweber D. VEcadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 1997;110 (Pt 5): 583-588.
28. Monteiro AC, Luissint AC, Sumagin R, Lai C, Vielmuth F, Wolf MF, Laur O, Reiss K, Spindler V, Stehle T, Dermody TS, Nusrat A, Parkos CA. Trans-dimerization of JAM-A regulates Rap2 and is mediated by a domain that is distinct from the cisdimerization interface. Mol Biol Cell 2014;25:1574-1585.
29. Baumgartner W, Hinterdorfer P, Ness W, Raab A, Vestweber D, Schindler H, Drenckhahn D. Cadherin interaction probed by atomic force microscopy. Proc Natl Acad Sci USA 2000;97:4005-4010.
30. Schlegel N,Waschke J. cAMP with other signaling cues converges on Rac1 to stabilize the endothelial barrier- a signaling pathway compromised in inflammation. Cell Tissue Res 2014;355:587-596.
31. Lambeng N, Wallez Y, Rampon C, Cand F, Christe G, Gulino-Debrac D, Vilgrain I, Huber P. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 2005;96:384-391.
32. Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loet X, Vittecoq O, Vilgrain I. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage. Arthritis Rheum 2012;64:77-87.
33. Herren B, Levkau B, Raines EW, Ross R. Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell 1998;9:1589-1601.
34. Lin YC, Adamson RH, Clark JF, Reed RK, Curry FR. Phosphodiesterase 4 inhibition attenuates plasma volume loss and transvascular exchange in volume-expanded mice. J Physiol 2012;590:309-322.
35. Lin YC, Samardzic H, Adamson RH, Renkin EM, Clark JF, Reed RK, Curry FR. Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume. J Physiol 2011;589:341-353.
36. Schick MA, Wunder C, Wollborn J, Roewer N, Waschke J, Germer CT, Schlegel N. Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation. J Physiol 2012;590:2693-2708.
37. Schlegel N, Waschke J. VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am J Physiol Cell Physiol 2009;296:C453-C462.
38. Boulday G, Coupel S, Coulon F, Soulillou JP, Charreau B. Antigraft antibody-mediated expression of metalloproteinases on endothelial cells. Differential expression of TIMP-1 and ADAM-10 depends on antibody specificity and isotype. Circ Res 2001;88: 430-437.
39. Curry FR, Adamson RH. Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc Res 2010;87: 218-229.
40. Postina R. Activation of alpha-secretase cleavage. J Neurochem 2012;120(Suppl. 1): 46-54.
41. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 2001;97: 1679-1684.
42. Fleck A, Hawker F, Wallace PI, Raines G, Trotter J, Ledingham IM, Calman KC. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985;325:781-784.